Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular proteins and thiols represent a broad and heterogeneous class of molecules characterized by the presence of reactive sulfhydryl (-SH) functional groups, which are essential for maintaining cellular redox homeostasis and structural integrity. This category includes the tripeptide glutathione (GSH), the most abundant non-protein thiol, as well as a vast array of cysteine-containing proteins that participate in redox signaling and enzymatic catalysis (PubChem, CID 124886). In pharmacology, these molecules often act as a 'sink' or non-specific site of action for electrophilic drugs, such as platinum-based chemotherapeutics and alkylating agents, which can lead to drug sequestration and the development of chemoresistance (PubMed, PMID: 11485329). While not a discrete therapeutic target, the modulation of thiol levels is a key strategy in treating oxidative stress-related conditions and heavy metal poisoning (StatPearls, NBK537183). Because this term encompasses thousands of distinct molecular species across various cellular compartments, it is considered too broad to serve as a specific canonical drug target in modern molecular pharmacology.
Drugs interact with cellular proteins and thiols primarily through covalent binding to nucleophilic sulfhydryl (-SH) groups, leading to the formation of adducts, depletion of antioxidant pools like glutathione, or the inhibition of thiol-dependent enzymes. Some agents, like N-acetylcysteine, act as precursors to replenish these thiol pools and restore redox balance.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular proteins and thiols.